Genetic sequencing of a cancer patient's tumors without comparing it to their normal tissues can lead to misdirected treatment, researchers suggest. Not all mutations seen in a tumor are necessarily driving the cancer, they say.
Genetic sequencing of a cancer patient's tumors without comparing it to their normal tissues can lead to misdirected treatment, researchers suggest. Not all mutations seen in a tumor are necessarily driving the cancer, they say.